EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of acquired immune deficiency syndrome wasting on the protein metabolic response to acute exercise






Metabolism: Clinical and Experimental 50(3): 288-292

Effect of acquired immune deficiency syndrome wasting on the protein metabolic response to acute exercise

Wasting is a major complication of human immunodeficiency virus (HIV) infection, which remains prevalent even in the era of highly-active antiretroviral therapy. We have previously shown that progressive resistance exercise can increase lean body mass (LBM) significantly in patients with wasting, and that exercise does not increase circulating HIV RNA concentrations. We examined the effect of one bout of moderately difficult exercise on whole body protein kinetics in 10 patients with HIV wasting and 12 patients with HIV infection without wasting in Massachusetts, USA [date not given]. At baseline, there were no differences between the groups in whole body leucine flux, oxidation, or nonoxidative leucine disposal (NOLD, a measure of whole body protein synthesis). Six days after exercise, NOLD was significantly higher in the wasted patients compared with the nonwasted ones (82.2 +or- 16.7 v 66.5 +or- 15.2 micro mol/kg LBM/h, P<0.03). The change in NOLD between baseline and day 6 was significantly different between the 2 groups (+9.0 +or- 9.2 v -3.3 +or- 5.7 micro mol/kg LBM/h, P<0.02). These data indicate that the ability to respond to exercise with protein synthesis is maintained in HIV wasting.

Accession: 003414638

PMID: 11230780

DOI: 10.1053/meta.2001.21017

Download PDF Full Text: Effect of acquired immune deficiency syndrome wasting on the protein metabolic response to acute exercise



Related references

Arey, B.D.; Beal, M.W., 2002: The role of exercise in the prevention and treatment of wasting in acquired immune deficiency syndrome. Involuntary weight loss with lean tissue depletion is a serious and AIDS-defining complication of HIV infection. This article explores definitions of AIDS wasting syndrome (AWS), its etiology, methods of assessing body composition, and pharmacolog...

Schupbach J.; Haller O.; Vogt M.; Luthy R.; Joller H.; Oelz O.; Popovic M.; Sarnagadharan M.G.; Gallo R.C., 1985: Antibodies to human t cell leukemia virus type iii in swiss patients with acquired immune deficiency syndrome and pre acquired immune deficiency syndrome and groups at risk for acquired immune deficiency syndrome. Serum samples from Swiss subjects were tested by 3 different assays based on enzyme-linked immunosorbent assay (ELISA) and Western blot techniques for antibodies to proteins associated with the recently discovered human T-cell leukemia/lymphoma vi...

Levy J.A.; Shimabukuro J., 1985: Recovery of acquired immune deficiency syndrome associated retroviruses from patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome related conditions and from clinically healthy individuals. Lymphocytopathic retroviruses have been recovered from the peripheral mononuclear cells of over 160 individuals in all segments of the population known to be at risk for developing AIDS. They have not been isolated from individuals coming from out...

Murray J.L.; Hersh E.M.; Reuben J.M.; Munn C.G.; Mansell P.W.A., 1985: Abnormal lymphocyte response to exogenous interleukin 2 in homosexuals with acquired immune deficiency syndrome and acquired immune deficiency syndrome related complex. Interleukin-2- (IL-2) production as well as the response of lymphocytes to exogenous IL-2 was measured in asymptomatic homosexuals, patients with acquired immune deficiency syndrome (AIDS) and homosexuals with prodromal symptoms. IL-2 production f...

Patt Y.Z.; Mansell P.W.A.; Reuben J.M.; Claghorn L.; L.S.; Gehan E.; Hersh E.M., 1986: Effect of azimexon therapy on host defense parameters and disease associated symptoms in the acquired immune deficiency syndrome and acquired immune deficiency syndrome related complex. Azimexon, a 2-cyan-aziridinyl immune modulator, was given at a dose of 250 mg/m2/day for 10 days IV to 12 patients with AIDS and 16 with AIDS related complex (ARC). A decrease in total number of AIDS related symptoms from 43 to 24 and in mean numb...

Fairfield, W.P.; Finkelstein, J.S.; Klibanski, A.; Grinspoon, S.K., 2001: Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. Multiple endocrine and metabolic consequences of human immunodeficiency virus (HIV) infection exist that may contribute to bone loss in men with the acquired immune deficiency syndrome (AIDS) wasting syndrome. Recent studies suggest that anabolic...

Zolla Pazner S.; E.S.dr W.; William D.; Stahl R.; Marmor M., 1985: The use of beta 2 microglobulin in the diagnosis of acquired immune deficiency syndrome suspected acquired immune deficiency syndrome and preclinical acquired immune deficiency syndrome. Selikoff, I J , A S Teirstein And S Z Hirschman (Ed ) Annals Of The New York Academy Of Sciences, Vol 437 Acquired Immune Deficiency Syndrome; Meeting, New York, N Y , Usa, Nov 14-17, 1983 Xiv+622p The New York Academy Of Sciences; New York, N Y , Usa Illus 526-529, 1984

Redfield R.R.; Markham P.D.; Salahuddin S.Z.; Wright D.C.; Sarngadharan M.G.; Gallo R.C., 1985: Heterosexually acquired human t cell lymphotropic virus type iii lymphadenopathy associated disease acquired immune deficiency syndrome related complex and acquired immune deficiency syndrome epidemiologic evidence for female to male transmission. Thirty-seven percent (15/41) of patients with human T-cell lymhotropic virus type III (HTLV-III) disease (acquired immunodeficiency syndrome [AIDS] or AIDS-related complex) sequentially evaluated at Walter Reed Army Medical Center, Washington, DC,...

Silverman B.A.; Rubinstein A., 1985: Serum lactate dehydrogenase levels in adults and children with acquired immune deficiency syndrome and acquired immune deficiency syndrome related complex possible indicator of b cell lymphoproliferation and disease activity effect of intravenous gamma globulin on enzyme levels. Patients (27 of 33) with the acquired immune deficiency syndrome (AIDS) or AIDS-related complex (16 adults and 17 children) demonstrated significant elevation of serum lactate dehydrogenase activity, occurring in the isomorphic distribution. Serum...

Patterson, B.K.; Ehrenpreis, E.D.; Yokoo, H., 1993: Focal enterocyte vacuolization. A new microscopic finding in the acquired immune deficiency wasting syndrome. Vacuolization of duodenal enterocytes was found by light microscopic examination in five patients meeting the Centers for Disease Control criteria for the acquired immunodeficiency wasting syndrome. Four of these patients had chronic diarrhea and...